Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V36546 | KR-12 (human) | KR-12 (human) is a peptide compound. | ||
V35575 | L-Alanyl-L-leucine | 3303-34-2 | L-Alanyl-L-leucine is an endogenously produced metabolite. | |
V35294 | L-Alanyl-L-tryptophan | 16305-75-2 | L-Alanyl-L-tryptophan is a peptide compound. | |
V37101 | L-Leucyl-L-Leucine methyl ester HBr | 16689-14-8 | L-Leucyl-L-Leucine methyl ester (LLOMe) HBr is a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, which can selectively eliminate lymphocytes with cytotoxic potential. | |
V36536 | Laminin Nonapeptide, amide | 110590-61-9 | Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 is a linear peptide developed from the laminin B1 chain that interferes with tumor cell attachment and invasion into the basement membrane and has anti-angiogenic effects. | |
V4355 | LANREOTIDE | 108736-35-2 | Lanreotide (Ipstyl; Somatulin;BIM-23014; Lanreotide Autogel), a synthetic somatostatin analogue, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. | |
V4356 | LANREOTIDE ACETATE | 127984-74-1 | Lanreotide acetate (BIM-23014;Ipstyl; BIM 23014; Somatulin), the acetate salt of lanreotide which is a synthetic somatostatin analogue, is an approved anticancer medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. | |
V12565 | LCKLSL | 533902-29-3 | LCKLSL is an N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor that can effectively inhibit the binding of tissue plasminogen activator (tPA) to AnxA2. | |
V35584 | Leiurotoxin I | 142948-19-4 | Scyllatoxin (Leiurotoxin I) is a bioactive peptide toxin extracted from the venom of the scorpion (Leiurus quinquestriatus hebraeus). | |
V36502 | Lepirudin | 138068-37-8 | Lepirudin is a potent irreversible thrombin inhibitor. | |
V36544 | Leptin (138-167) (human) | Leptin (138-167) (human) is a peptide compound. | ||
V36545 | Leptin (150-167) (human) | 200436-46-0 | Leptin (150-167) (human) is a peptide compound. | |
V36543 | Leptin (93-105) (human) | 200436-43-7 | Leptin (93-105) is the 93-105 amino acid (AA) fragment of human leptin. | |
V36743 | Leu-Enkephalin, amide | Leu-Enkephalin, amide is a peptide compound. | ||
V37121 | Leu-Gly|H-Leu-Gly-OH | 686-50-0 | H-Leu-Gly-OH is a glycine analogue. | |
V37107 | Leu-Leu.HCl|H-Leu-Leu-OH.HCl | 3303-31-9 | Leu-Leu-OH is a Leu analogue, a dipeptide. | |
V35586 | Leu-Ser-Lys-Leu | 162559-45-7 | H-Leu-Ser-Lys-Leu-OH is a delay-related peptide located at the amino terminus of LAP and has an inhibitory activity against TGF-β1 activation. | |
V34883 | Leu-Valorphin-Arg | 135861-77-7 | Leu-Valorphin-Arg is a peptide compound. | |
V35585 | Leucokinin III | 104958-71-6 | Leucokinin III is a peptide compound. | |
V35587 | LHRH | 35263-73-1 | LHRH, gonadotropin-releasing hormone, is a hypothalamic neuropeptide. |